Can 18 F-FDG-Positron Emission Tomography be a Prognostic Tool in Children With Rhabdomyosarcoma Treated With Definitive Radiotherapy?
J Pediatr Hematol Oncol
; 45(3): e363-e369, 2023 04 01.
Article
in En
| MEDLINE
| ID: mdl-36251857
Full text:
1
Database:
MEDLINE
Main subject:
Rhabdomyosarcoma
/
Fluorodeoxyglucose F18
Type of study:
Prognostic_studies
Limits:
Adolescent
/
Child
/
Humans
Language:
En
Journal:
J Pediatr Hematol Oncol
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
/
PEDIATRIA
Year:
2023
Type:
Article